Noviocell

Oss, Netherlands Founded: 2015 • Age: 11 yrs
Developer of 3D cell culture technology for life science research
Annual revenue - Latest available
Total funding - 2 rounds
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 7 Brand Intelligence

About Noviocell

Noviocell is a company based in Oss (Netherlands) founded in 2015. Noviocell operates in a competitive market with competitors including Biogelx, Gel Coat Biomaterials, SPES Tech, Matrix Bio and PepGel, among others.

  • Headquarter Oss, Netherlands
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $747.87 K (USD), Grant

    Jan 01, 2017

  • Investors
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Noviocell

Investors in Noviocell

Noviocell has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Noviocell

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Noviocell

Investments
Premium access

Investment portfolio details for Noviocell

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Noviocell

Premium access

Detailed financials for Noviocell

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Noviocell Comparisons

Noviocell Primary company
Description
Developer of 3D cell culture technology for life science res...
Location
Oss, Netherlands
Founded Year
2015
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Noviocell

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Noviocell

Noviocell operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biogelx, Gel Coat Biomaterials, SPES Tech, Matrix Bio and PepGel, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Peptide hydrogels and preparation protocols are supplied for cell culture.
Locked Locked Locked
Hydrogel technology is developed for biomaterials and medical uses.
Locked Locked Locked
Develops recombinant protein hydrogel technology for cell culture applications.
Locked Locked Locked
Develops AI tools for optimizing hydrogels in 3D cell culture research.
Locked Locked Locked
Self-healing hydrogels for 3D cell culture are developed and commercialized.
Premium access

Detailed competitors of Noviocell

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Noviocell

Premium access

Complete news archive for Noviocell

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Noviocell

Noviocell was founded in 2015 and raised its 1st funding round 1 year after it was founded.

Noviocell is headquartered in Oss, Netherlands. It is registered at Oss, Noord-brabant, Netherlands.

Developer of 3D cell culture technology for life science research. It offers proprietary hydrogel technologies the soft thermo-responsive helical oligo glycol polyisocyanopeptides hydrogel and the programmed self-assembly of peptide-modified cyclohexane triacid derivatives into self-assembled nanofibers for biomedical researchers, biotech and pharma industry and clinicians.

Noviocell's top competitors include Biogelx, Gel Coat Biomaterials and PepGel.

Noviocell has 1 investor. Key investors include European Union.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available